EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems

Yusuf A Haggag iD, Abeer A Abd Elrahman iD, Roland Ulber iD, Ahmed Zayed iD

Marine Drugs · 04.02.2023 · 21 (2) · 112

DOI: 10.3390/md21020112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 04.02.2023. Verfasst von Yusuf A Haggag und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, El-Geish Street, Tanta 31527, Egypt. Hauptthemen laut MEDLINE: Polysaccharides, Drug Delivery Systems. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fucoidan is a heterogeneous group of polysaccharides isolated from marine organisms, including brown algae and marine invertebrates. The physicochemical characteristics and potential bioactivities of fucoidan have attracted substantial interest in pharmaceutical industries in the past few decades. These polysaccharides are characterized by possessing sulfate ester groups that impart negatively charged surfaces, low/high molecular weight, and water solubility. In addition, various promising bioactivities have been reported, such as antitumor, immunomodulatory, and antiviral effects. Hence, the formulation of fucoidan has been investigated in the past few years in diverse pharmaceutical dosage forms to be able to reach their site of action effectively. Moreover, they can act as carriers for various drugs in value-added drug delivery systems. The current work highlights the attractive biopharmaceutical properties of fucoidan being formulated in oral, inhalable, topical, injectable, and other advanced formulations treating life-quality-affecting diseases. Therefore, the present work points out the current status of fucoidan pharmaceutical formulations for future research transferring their application from in vitro and in vivo studies to clinical application and market availability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesDrug Delivery SystemsDrug CompoundingPharmaceutical PreparationsAquatic Organisms

Stichwörter der Autor:innen

drug deliveryformulationfucoidannanotechnologypharmaceutical industry

Substanzen

fucoidanPolysaccharidesPharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, El-Geish Street, Tanta 31527, Egypt.
  • Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA.
  • Institute of Bioprocess Engineering, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Street 49, 67663 Kaiserslautern, Germany.
  • Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, El-Guish Street, Tanta 31527, Egypt.

ORCID-Profile: Yusuf A Haggag, Abeer A Abd Elrahman, Roland Ulber, Ahmed Zayed

Förderung

  • Ministry of Higher Education

Zitieren

APA

Haggag, Y. A., Abd Elrahman, A. A., Ulber, R., & Zayed, A. (2023). Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems. Marine Drugs, 21(2), 112. https://doi.org/10.3390/md21020112

Vancouver

Haggag YA, Abd Elrahman AA, Ulber R, Zayed A. Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems. Marine Drugs. 2023;21(2):112. doi:10.3390/md21020112

BibTeX
@article{Haggag2023,
  author = {Haggag, Yusuf A and Abd Elrahman, Abeer A and Ulber, Roland and Zayed, Ahmed},
  title = {Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems},
  journal = {Marine Drugs},
  year = {2023},
  volume = {21},
  number = {2},
  pages = {112},
  doi = {10.3390/md21020112}
}
Kostenlos starten →